Find clinical trials for Endometrial Cancer in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Columbus, OH, USA:
The goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial...
Columbus, Ohio, United States and 8 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Columbus, Ohio, United States and 305 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Hilliard, Ohio, United States and 66 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Columbus, Ohio, United States and 246 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Columbus, Ohio, United States and 82 other locations
amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample.In Cohort 1, the main goal is to assess how well BNT323 (als...
Phase 3
Hilliard, Ohio, United States and 131 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Columbus, Ohio, United States and 188 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Columbus, Ohio, United States and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Columbus, Ohio, United States and 73 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Hilliard, Ohio, United States and 89 other locations
Clinical trials
Research sites
Resources
Legal